CRISPRi systems using catalytic inactive St1Cas9 or SpCas9 or Francisella novicida Cas12a (FnCas12a) has been developed for gene silencing in mycobacteria. However, these systems can only achieve partial gene knockdown and will cause polar effect that the operonic genes downstream of the Cas protein binding sites will also be silenced .